Applications are now being accepted for the Alberta MS Collaboration Translation, Commercialization and Implementation Grant Competition
The Alberta Multiple Sclerosis Collaboration (Alberta MS Collaboration) is accepting proposals from Alberta-based investigators for multiple sclerosis (MS) projects with translation, implementation, and/or commercialization potential.
The Alberta MS Collaboration is a multi-stakeholder initiative supporting innovation in MS research and translation in Alberta. Current partners include the Alberta MS Network, Alberta Economic Development and Trade, Alberta Health, Campus Alberta Neuroscience, the MS Society of Canada, and Sanofi Genzyme Canada. Funding for the current competition was provided by Alberta Economic Development and Trade, Sanofi Genzyme Canada.
The purpose of the translation, implementation, and/or commercialization grant competition is to fund Alberta MS researchers to advance their discoveries or inventions toward translation, commercialization and/or implementation opportunities that will strengthen Alberta’s capacity for rapid translation of research to impact. A maximum of two projects will be funded at up to $42,000 CAD total (including all direct and indirect costs), over a one-year period.
The deadline for applications is February 15, 2019. For more details on the competition, please view the RFP.
Applications can be submitted through the MS Society of Canada’s Easygrants system.